Upper Limb Task-Oriented Rehabilitation With Robotic Exoskeleton for Hemiparetic Stroke Patients

Chronic Disease Clinical Trial

— RH-LEXOS  

Official title:

Robotic Assisted Task-Oriented Rehabilitation of Upper Limb for Chronic Stroke Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03319992
• Other study ID #: RH-UL-LEXOS-10
• Status: Completed
• Phase: Phase 2
• Start date: July 20, 2016
• Est. completion date: November 30, 2018

Study information

• Verified date: April 2021
• Source: Scuola Superiore Sant'Anna di Pisa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effects of an assisted rehabilitation treatment through a robotic exoskeleton device on the functional recovery in a group of patients with hemiparesis from lesion of the first motor neuron (post-stroke), compared with a group of patients subjected to a conventional rehabilitation treatment. The patients enrolled in the study are chronic stroke injured with right hemiparesis of moderate to severe degree, by the system injury pyramid, never undergoing rehabilitation treatment with robots.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: November 30, 2018
• Est. primary completion date: October 20, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• diagnosis of a first-ever left hemisphere ischemic or hemorrhagic stroke at least 6 months prior to entry into the study;

• minimum ability for shoulder humeral elevation;

• upper-extremity motor function Fugl-Meyer (FM) score = 15(out of 66);

• absence of neurological or muscular disorders that interfere with neuromuscular function;

• absence of severe cognitive deficits that would limit patients' ability to complete the study;

• minimum score of 2 in the Modified Ashworth Scale;

• not participating in any experimental rehabilitation or drug studies at the same time

• no previous experience with robotic treatments.

Related Conditions & MeSH terms

• Cerebrovascular Accident (CVA)
• Chronic Disease
• Stroke
• Stroke Rehabilitation

Intervention

Device:
• Upper Arm Rehabilitation Light Exoskeleton (RH-LEXOS)
RH-LEXOS is a robotic exoskeleton device to support the rehabilitation of stroke patients. This system is conceived for the force assistance, integrated in a Virtual Reality system that allows implementing rehabilitative exercises highly interactive and engaging for the patients. Passive, assisted and active mobilization of upper arm is provided through the use of the exoskeleton robotic device within high intensive, repetitive, task-oriented exercises and an objective and reliable mean for monitoring patients' progress.

Locations

Country	Name	City	State
Italy	University Hospital of Pisa	Pisa

Sponsors (2)

Lead Sponsor	Collaborator
Scuola Superiore Sant'Anna di Pisa	Azienda Ospedaliero, Universitaria Pisana

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Fugl-Meyer Assessment (FMA( Score	The null hypothesis tested in this study was the change in motor function domain of the upper extremity portion of the Fugl-Meyer assessment in the Robotic Group (Robotic Treatment) would be the same as the one obtained by the Control Group (Conventional Treatment).; The FMA outcome is further divided and analyzed in terms of sub-items. In particular, the motor FMA score is divided into proximal (shoulder and elbow movement, 36 points) and distal (hand and wrist movement, 24 points) sub-items.	baseline and 6 weeks
Secondary	Functional scale: Bimanual Activity Test (BAT)	The BAT is a functional scale designed to quantify the contribution of patient's affected upper limb to execute 25 common Activities of Daily Living such as Loosen and tighten the cap of a bottle , or unscrew a bolt. The elapsed time for accomplishing each task is measured and the therapist also give a score (ranging from 1 to 4) about the quality of each movement.; The BAT data is analyzed also in terms of sub-items, divided into pinch-tasks and power-tasks collecting those items requiring fine and gross manipulation motor skills respectively.	baseline and 6 weeks
Secondary	Modified Ashworth (MA) scale	The MA scale (Bohannon and Smith, 1987) is used to evaluate spasticity of the upper limb and to assess abnormal muscle tone at the shoulder and elbow. The MA scale is a 6-point scale: scores range from 0 to 4, where lower scores represent normal muscle tone and higher scores represent spasticity or increased resistance to passive movement. MA scores were averaged across the two joints and across testing directions (flexion, extension) to estimate abnormal muscle tone in the upper extremity (Zackowski, Dromerick et al., 2004)	baseline and 6 weeks
Secondary	Robotic kinesiological assessment of movement: Execution Time	This measure is evaluated only in the group of patients performing robotic training, at the end of each session through the analysis of their performance during the execution of an evaluation exercise without robotic assistance.The patients are instructed to reach different targets positioned in front of them and placed around a vertical circumference at 12 equally spaced locations.; The robotic measure is extracted for each outgoing (from the center to the target) movement. The execution time is measured as the elapsed time (measure in seconds) for accomplishing each movement, measured from the time of grasping of the virtual object at the start position to the release time at the target position.	At end of each session, during 6 weeks of enrollment in treatment
Secondary	Robotic kinesiological assessment of movement: Smoothness index	This measure is evaluated only in the group of patients performing robotic training, at the end of each session through the analysis of their performance during the execution of an evaluation exercise without robotic assistance.The patients are instructed to reach different targets positioned in front of them and placed around a vertical circumference at 12 equally spaced locations.; The robotic measure is extracted for each outgoing (from the center to the target) movement.; The smoothness index is computed in the same interval period by counting the number of peaks in the velocity profile of movement, namely the Number of Movements Units (NMU) (Fasoli S, Krebs J Neurosci 2002)	At end of each session, during 6 weeks of enrollment in treatment